Furthermore, Huang et al. found that SMAD2/3 signalling controls endometrial regeneration and differentiation and that mice with SMAD2/3 conditional deletion develop metastatic uterine tumours and that SMAD2/3 inactivation affects the morphology and differentiation of uterine-like organs. This evidence concerns the gene SMAD2 and tumor of uterus.